NUF2 expression positively correlates with tumor-infiltrating CD8+ T cells and dendritic cells in clear renal cell carcinoma, while POLA2 has been identified as a positive biomarker for PD-L1 blockade response in mUC. This evidence concerns the gene NUF2 and neoplasm.